Viridian Therapeutics, Inc.\DE (VRDN) Other Accumulated Expenses (2013 - 2016)

Viridian Therapeutics, Inc.\DE's Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $4000.0 for Q4 2016.

• On a quarterly basis, Other Accumulated Expenses fell 95.24% year-over-year to $4000.0 in Q4 2016; TTM through Dec 2016 was $4000.0, a 95.24% decrease from a year earlier, with the FY2016 full-year figure at $4000.0, down 95.24% from the prior year.
• Other Accumulated Expenses eased to $4000.0 in Q4 2016 per VRDN's latest filing, from $228000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $228000.0 in Q3 2016 and bottomed at $4000.0 in Q4 2016.
• The 4-year median for Other Accumulated Expenses is $64500.0 (2014), against an average of $78263.2.
• Biggest YoY gain for Other Accumulated Expenses was 125.74% in 2016; the steepest drop was 95.24% in 2016.
• Year by year, Other Accumulated Expenses stood at $40000.0 in 2013, then surged by 55.0% to $62000.0 in 2014, then jumped by 35.48% to $84000.0 in 2015, then sank by 95.24% to $4000.0 in 2016.
• Per Business Quant, the three latest VRDN Other Accumulated Expenses figures stand at $4000.0 (Q4 2016), $228000.0 (Q3 2016), and $67000.0 (Q2 2016).